Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization

Abstract

Background— The American Heart Association’s 2020 Strategic Goals emphasize the value of optimizing risk factor status to reduce the burden of morbidity and mortality. In this study, we aimed to quantify the overall and marginal impact of favorable cardiovascular risk factor (CRF) profile on healthcare expenditure and resource utilization in the United States among those with and without cardiovascular disease (CVD). Methods and Results— The study population was derived from the 2012 Medical Expenditure Panel Survey (MEPS). Direct and indirect costs were calculated for all-cause healthcare resource utilization. Variables of interest included CVD diagnoses (coronary artery disease, stroke, peripheral artery disease, dysrhythmias, or heart failure), ascertained by International Classification of Diseases , Ninth Edition, Clinical Modification codes, and CRF profile (hypertension, diabetes mellitus, hypercholesterolemia, smoking, physical activity, and obesity). Two-part econometric models were used to study expenditure data. The final study sample consisted of 15 651 MEPS participants (58.5±12 years, 54% female). Overall, 5921 (37.8%) had optimal, 7002 (44.7%) had average, and 2728 (17.4%) had poor CRF profile, translating to 54.2, 64.1, and 24.9 million adults in United States, respectively. Significantly lower health expenditures were noted with favorable CRF profile across CVD status. Among study participants with established CVD, overall healthcare expenditures with optimal and average CRF profile were $5946 and $3731 less compared with those with poor CRF profile. The respective differences were $4031 and $2560 in those without CVD. Conclusions— Favorable CRF profile is associated with significantly lower medical expenditure and healthcare utilization among individuals with and without established CVD.

Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association

“…Healthcare costs included hospitalizations, prescribed medications, outpatient visits (hospital outpatient visits and office-based visits), ED visits, and other expenditures (dental visits, vision aid, home health care, and other medical supplies). 34 …”

Patient–Provider Communication and Health Outcomes Among Individuals With Atherosclerotic Cardiovascular Disease in the United States

“…We included respondents with at least 1 of hypercholesterolemia, hypertension, diabetes mellitus, lack of physical exercise (defined as lack of moderate-vigorous physical activity, ≥30 min, ≥ 5× per week), smoking, or obesity (body mass index ≥30 kg/m 2 , derived using self-reported weight and height by the individuals). 13 Comorbid disease burden was estimated using the Grouped Charlson comorbidity index, which has been described in detail elsewhere. 14,15 We accounted for these factors in our statistical analysis, to control any probable influence they may have on the association between PPC and the outcomes studied.…”

Trends in Healthcare Expenditures Among US Adults With Hypertension: National Estimates, 2003–2014

“…Projections from 2001 to 2005 Medical Expenditure Panel Survey (MEPS) data suggest that hypertension is the costliest of all cardiovascular diseases, with an estimated direct cost of $69.9 billion in 2010 . However, many prior hypertension cost projections are limited because they include hypertension in an aggregate definition of cardiovascular disease, making it difficult to parse out costs related to hypertension versus those from stroke or heart failure . Additionally, prior work has used older data to project into the future rather than analyzing trends in expenditure over time …”